nference Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 419
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $61M
Latest Deal Amount
  • Investors
  • 4

nference General Information

Description

Developer of a holistic software intended to synthesize the exponentially growing biomedical knowledge. The company's software utilizes neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets, enabling healthcare enterprises to make biomedical knowledge computable.

Contact Information

Website
www.nference.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • One Main Street, Suite 400
  • East Arcade, 4th Floor
  • Cambridge, MA 02142
  • United States

nference Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

nference Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 15-Dec-2020 $61M 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 08-Jan-2020 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Jun-2018 $12M $15M 000.00 Completed Generating Revenue
1. Seed Round 10-Jan-2016 $3M $3M 000 Completed Generating Revenue
To view nference’s complete valuation and funding history, request access »

nference Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B-1 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 3,105,591 $0.001000 $3.54 $3.54 1x $3.54 2.59%
Seed 6,635,687 $0.001000 $0.48 $0.48 1x $0.48 5.53%
To view nference’s complete cap table history, request access »

nference Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a holistic software intended to synthesize the exponentially growing biomedical knowledge. The company's so
Other Healthcare Technology Systems
Cambridge, MA
419 As of 2021
00000
0000 0000-00-00
00000000000 00000

00000 00

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
00000000 00000000
London, United Kingdom
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

00000 00

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
0000 000000000
San Francisco, CA
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

nference Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eagle Genomics Venture Capital-Backed London, United Kingdom 00 0000 00000000000 0000
00000 00000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000
000000000 Formerly VC-backed Salt Lake City, UT 000 00000 00000000 00000
00000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

nference Executive Team (18)

Name Title Board Seat Contact Info
Murali Aravamudan Co-Founder, Chief Executive Officer & Board Member
Ajit Rajasekharan Chief Technology Officer
Michael Durso Chief Sales Officer
Venky Soundararajan Ph.D Co-Founder & Chief Scientific Officer
Anita Kawatra Chief Corporate Affairs Officer
You’re viewing 5 of 18 executive team members. Get the full list »

nference Board Members (5)

Name Representing Role Since
David Goel Matrix Capital Management Board Member 000 0000
John Halamka MD Self Board Member 000 0000
Murali Aravamudan nference Co-Founder, Chief Executive Officer & Board Member 000 0000
Tim Barrows Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

nference Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

nference Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
NTTVC Venture Capital Minority 000 0000 000000 0
Matrix Partners Venture Capital Minority 000 0000 000000 0
Matrix Capital Management Hedge Fund Minority 000 0000 000000 0
To view nference’s complete investors history, request access »

nference Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 14-Apr-2021 00000 0000000 Other Healthcare Technology Systems
00000000 00000000 01-Apr-2020 000000000000000000 000 Outcome Management (Healthcare)
Qrativ 14-Jul-2017 Joint Venture Drug Discovery
To view nference’s complete investments and acquisitions history, request access »